日韩成人无码毛片,成人无码A级毛片免费播放,精品乱码一区内射人妻无码,强伦轩人妻一区二区三区四区,欧美一级婬片AAAAAAA欠钱,亚洲精品乱码久久久久久蜜桃91,中文在线字幕免费观看,免费看无码一级A片放24小时 ,精品人妻少妇嫩草AV无码专区,99人妻碰碰碰久久久久禁片,国内精品一区二区,老熟妇欲乱AV无码 ,国产69精品久久久久久久久久久久,www.17c路com,国产成人在线视频,91久久精品国自产合

最近搜索:細(xì)胞培養(yǎng) 微生物學(xué) 分子生物 生物化學(xué)
首頁>>免疫學(xué)>>一抗>>干擾素調(diào)節(jié)因子7重組兔單克隆抗體
干擾素調(diào)節(jié)因子7重組兔單克隆抗體
  • 產(chǎn)品貨號(hào):
    BN42086R
  • 中文名稱:
    干擾素調(diào)節(jié)因子7重組兔單克隆抗體
  • 英文名稱:
    Rabbit anti-IRF7 Monoclonal antibody
  • 品牌:
    Biorigin
  • 貨號(hào)

    產(chǎn)品規(guī)格

    售價(jià)

    備注

  • BN42086R-50ul

    50ul

    ¥2020.00

    交叉反應(yīng):Human 推薦應(yīng)用:WB

  • BN42086R-100ul

    100ul

    ¥3240.00

    交叉反應(yīng):Human 推薦應(yīng)用:WB

產(chǎn)品描述

英文名稱IRF7
中文名稱干擾素調(diào)節(jié)因子7重組兔單克隆抗體
別    名IRF 7; IRF-7; Interferon regulatory factor 7; Interferon regulatory factor 7H; IRF 7; IRF 7A; IRF 7H; IRF7A; IRF7; IRF7H; IRF7_HUMAN.  
研究領(lǐng)域腫瘤  免疫學(xué)  細(xì)胞凋亡  轉(zhuǎn)錄調(diào)節(jié)因子  
抗體來源Rabbit
克隆類型Monoclonal
克 隆 號(hào)2A1
交叉反應(yīng)Human, 
產(chǎn)品應(yīng)用WB=1:500-2000 
not yet tested in other applications.
optimal dilutions/concentrations should be determined by the end user.
分 子 量54kDa
細(xì)胞定位細(xì)胞核 細(xì)胞漿 
性    狀Liquid
濃    度1mg/ml
免 疫 原Recombinant human IRF7 protein (200-300aa): 
亞    型IgG
純化方法affinity purified by Protein A
儲(chǔ) 存 液0.01M TBS(pH7.4) with 1% BSA, 0.03% Proclin300 and 50% Glycerol.
保存條件Shipped at 4℃. Store at -20 °C for one year. Avoid repeated freeze/thaw cycles.
PubMedPubMed
產(chǎn)品介紹IRF7 encodes interferon regulatory factor 7, a member of the interferon regulatory transcription factor (IRF) family. IRF7 has been shown to play a role in the transcriptional activation of virus-inducible cellular genes, including interferon beta chain genes. Inducible expression of IRF7 is largely restricted to lymphoid tissue. Multiple IRF7 transcript variants have been identified, although the functional consequences of these have not yet been established. [provided by RefSeq, Jul 2008]

Function:
Key transcriptional regulator of type I interferon (IFN)-dependent immune responses and plays a critical role in the innate immune response against DNA and RNA viruses. Regulates the transcription of type I IFN genes (IFN-alpha and IFN-beta) and IFN-stimulated genes (ISG) by binding to an interferon-stimulated response element (ISRE) in their promoters. Can efficiently activate both the IFN-beta (IFNB) and the IFN-alpha (IFNA) genes and mediate their induction via both the virus-activated, MyD88-independent pathway and the TLR-activated, MyD88-dependent pathway. Required during both the early and late phases of the IFN gene induction but is more critical for the late than for the early phase. Exists in an inactive form in the cytoplasm of uninfected cells and following viral infection, double-stranded RNA (dsRNA), or toll-like receptor (TLR) signaling, becomes phosphorylated by IKBKE and TBK1 kinases. This induces a conformational change, leading to its dimerization and nuclear localization where along with other coactivators it can activate transcription of the type I IFN and ISG genes. Can also play a role in regulating adaptive immune responses by inducing PSMB9/LMP2 expression, either directly or through induction of IRF1. Binds to the Q promoter (Qp) of EBV nuclear antigen 1 a (EBNA1) and may play a role in the regulation of EBV latency. Can activate distinct gene expression programs in macrophages and regulate the anti-tumor properties of primary macrophages.

Subunit:
Monomer. Homodimer; phosphorylation-induced. Heterodimer with IRF3. Interacts with TICAM1 and TICAM2. Interacts with rotavirus A NSP1; this interaction leads to the proteasome-dependent degradation of IRF7. Interacts with Epstein-Barr virus LF2. Interacts with MYD88 AND TRAF6.

Subcellular Location:
Nucleus. Cytoplasm. Note=The phosphorylated and active form accumulates selectively in the nucleus.

Tissue Specificity:
Expressed predominantly in spleen, thymus and peripheral blood leukocytes.

Post-translational modifications:
Acetylation inhibits its DNA-binding ability and activity.
In response to a viral infection, phosphorylated on Ser-477 and Ser-479 by TBK1 and IKBKE1. Phosphorylation, and subsequent activation is inhibited by vaccinia virus protein E3. In TLR7- and TLR9-mediated signaling pathway, phosphorylated by IRAK1.
TRAF6-mediated ubiquitination is required for IRF7 activation (By similarity).
Sumoylated by TRIM28, which inhibits its transactivation activity.

Similarity:
Belongs to the IRF family.
Contains 1 IRF tryptophan pentad repeat DNA-binding domain.

SWISS:
Q92985

Gene ID:
3665

Database links:

Entrez Gene: 3665 Human

Entrez Gene: 54123 Mouse

Entrez Gene: 293624 Rat

Omim: 605047 Human

SwissProt: Q92985 Human

SwissProt: P70434 Mouse

Unigene: 166120 Human

Unigene: 3233 Mouse

Unigene: 101159 Rat



Important Note:
This product as supplied is intended for research use only, not for use in human, therapeutic or diagnostic applications.

























image.png

太谷县| 宜春市| 勐海县| 康定县| 友谊县| 株洲市| 桓仁| 雅安市| 大洼县| 兴隆县| 紫阳县| 古交市| 句容市| 武胜县| 温宿县| 拉萨市| 宜章县| 沾化县| 泽州县| 淮滨县| 龙海市| 贡觉县| 景洪市| 通化市| 时尚| 鄂伦春自治旗| 东明县| 六安市| 禄劝| 绥阳县| 白朗县| 五华县| 淮安市| 天柱县| 陇西县| 竹溪县| 壤塘县| 清河县| 南平市| 秭归县| 竹山县|